Breaking News

Evonik Breaks Ground for New Complex in Marl

Investing over €400 million to expand capacity for polyamide 12

By: Kristin Brooks

Managing Editor, Contract Pharma

Evonik began construction on its largest investment to date in Germany. The company is investing over €400 million to expand capacity for polyamide 12 (PA 12) by more than 50 percent at its largest site. The project will complement existing PA 12 production with additional plants for the polymer and its precursors. Startup is scheduled for 2021.

Christian Kullmann, the chairman of the executive board of Evonik Industries AG said, “This is the biggest single investment our company has made in Germany. We’re building this plant because we want to continue to grow with innovative specialty chemical products. With our high-performance polymer PA 12 we can supply global strategic growth markets such as 3D printing. But also in the automotive industry, our light-weight and long-lasting plastic makes an important contribution to resource efficiency.”

Evonik develops custom high-performance polymers for sophisticated applications. The Group is one of the world’s leading producers of PA 12, which the company sells under the brand name VESTAMID Granulate. Demand for the material from the automotive industry, oil and gas extraction, medicine, and athletics, is growing. 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters